Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 19,1 MB, PDF-dokument

  • Kunal S. Patel
  • Kaleab K. Tessema
  • Riki Kawaguchi
  • Lindsey Dudley
  • Alvaro G. Alvarado
  • Sree Deepthi Muthukrishnan
  • Travis Perryman
  • Akifumi Hagiwara
  • Vivek Swarup
  • Linda M. Liau
  • Anthony C. Wang
  • William Yong
  • Daniel H. Geschwind
  • Ichiro Nakano
  • Goldman, Steven Alan
  • Richard G. Everson
  • Benjamin M. Ellingson
  • Harley I. Kornblum
Background
Non-enhancing (NE) infiltrating tumor cells beyond the contrast-enhancing (CE) bulk of tumor are potential propagators of recurrence after gross total resection of high-grade glioma.

Methods
We leveraged single-nucleus RNA sequencing on 15 specimens from recurrent high-grade gliomas (n = 5) to compare prospectively identified biopsy specimens acquired from CE and NE regions. Additionally, 24 CE and 22 NE biopsies had immunohistochemical staining to validate RNA findings.

Results
Tumor cells in NE regions are enriched in neural progenitor cell-like cellular states, while CE regions are enriched in mesenchymal-like states. NE glioma cells have similar proportions of proliferative and putative glioma stem cells relative to CE regions, without significant differences in % Ki-67 staining. Tumor cells in NE regions exhibit upregulation of genes previously associated with lower grade gliomas. Our findings in recurrent GBM paralleled some of the findings in a re-analysis of a dataset from primary GBM. Cell-, gene-, and pathway-level analyses of the tumor microenvironment in the NE region reveal relative downregulation of tumor-mediated neovascularization and cell-mediated immune response, but increased glioma-to-nonpathological cell interactions.

Conclusions
This comprehensive analysis illustrates differing tumor and nontumor landscapes of CE and NE regions in high-grade gliomas, highlighting the NE region as an area harboring likely initiators of recurrence in a pro-tumor microenvironment and identifying possible targets for future design of NE-specific adjuvant therapy. These findings also support the aggressive approach to resection of tumor-bearing NE regions.
OriginalsprogEngelsk
Artikelnummervdae005
TidsskriftNeuro-Oncology Advances
Vol/bind6
Udgave nummer1
Antal sider14
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (H.I.K., R.K., S.A.G.); NIH grants P50 CA211015 (H.I.K., B.E., D.G., W.Y., L.L.), R01 NS121617 (H.I.K.), and F31 MH122205 (K.K.T.); the Broad Stem Cell Research Center (K.S.P., S.D.M.); the UC President’s Postdoctoral Fellowship Program (A.G.A.); the NIH National Center for Advancing Translational Science UCLA CTSI Grant KL2TR001882 (K.S.P.), and Neurosurgical Research Education Fund Young Clinical Investigator Award (K.S.P).

Publisher Copyright:
© The Author(s) 2024. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

ID: 384616965